首页 | 本学科首页   官方微博 | 高级检索  
     


Masked uncontrolled hypertension: Prevalence and predictors
Authors:Ghada Youssef  Sherif Nagy  Ahmed El-gengehe  Amr Abdel Aal  Magdy Abdel Hamid
Affiliation:1. Cairo University, Cairo, Egypt;2. Helwan University, Cairo, Egypt
Abstract:

Background

There are limited data on ‘masked uncontrolled hypertension’ (MUCH) in patients with treated and apparently well-controlled BP is unknown.

Objectives

To define the prevalence and predictors of MUCH among hypertensive patients with controlled office blood pressure.

Methods

One hundred ninety-nine hypertensive patients presented to the specialized hypertension clinics at two University Hospitals. All patients had controlled office blood pressure (less than 140/90?mmHg). Patients were assessed regarding history, clinical examination, and laboratory data. All patients underwent ambulatory blood pressure monitoring (ABPM) for 24?h, within a week after the index office visit. MUCH was diagnosed if average 24-h ABPM was elevated (systolic BP?≥?130?mmHg and/or diastolic BP?≥?80?mmHg) despite controlled clinic BP.

Results

Sixty-six patients (33.2%) had MUCH according to 24-h ABPM criteria (mean age 53.5?±?9.3?years, 60.6% men). MUCH was mostly caused by the poor control of nocturnal BP; with the percentage of patients in whom MUCH was solely attributable to an elevated nocturnal BP almost double that due to daytime BP elevation (57.3% vs. 27.1%, P?

Conclusion

The prevalence of masked suboptimal BP control is high. Office BP monitoring alone is thus inadequate to ascertain optimal BP control because many patients have an elevated nocturnal BP. ABPM is needed to confirm proper BP control, especially in patients with high cardiovascular risk profile. Smoking, DM and positive family history of DM were the most common predictors of MUCH.
Keywords:Ambulatory BP monitoring  Masked hypertension  Uncontrolled hypertension  A/C ratio  Albumin/Creatinine ratio  ABPM  Ambulatory Blood Pressure Monitoring  ACEI  Angiotensin Converting Enzyme Inhibitor  ARBs  Angiotensin Receptor Blockers  BB  Beta Blockers  BMI  Body Mass Index  BP  Blood Pressure  CAD  Coronary Artery Disease  CCB  Calcium Channel Blocker  CKD  Chronic Kidney Disease  CV  Cardio-Vascular  CVD  Cardio-Vascular Diseases  DBP  Diastolic Blood Pressure  DM  Diabetes Mellitus  ECG  ElectroCardioGram  HBPM  Home Blood Pressure Monitoring  HDL Cholesterol  High-Density Lipoprotein Cholesterol  HTN  Hypertension  LDL Cholesterol  Low-Density Lipoprotein Cholesterol  LVH  Left Ventricular Hypertrophy  MH  Masked Hypertension  MUCH  Masked Uncontrolled Hypertension  NHP  National Hypertension Project  SBP  Systolic Blood Pressure  SD  Standard Deviation  TOD  Target Organ damage
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号